Muhlenkamp & Co’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-18,218
| Closed | -$6.31M | – | 33 |
|
|
2021
Q2 | $6.31M | Buy |
18,218
+34
| +0.2% | +$11.8K | 2.31% | 25 |
|
|
2021
Q1 | $6.36M | Buy |
18,184
+37
| +0.2% | +$12.9K | 2.35% | 24 |
|
|
2020
Q4 | $4.44M | Buy |
18,147
+94
| +0.5% | +$23K | 1.79% | 26 |
|
|
2020
Q3 | $5.12M | Buy |
18,053
+222
| +1% | +$63K | 2.65% | 20 |
|
|
2020
Q2 | $4.77M | Buy |
+17,831
| New | +$4.77M | 2.55% | 20 |
|
|
2019
Q4 | $5.27M | Sell |
17,768
-6
| -0% | -$1.78K | 2.3% | 22 |
|
|
2019
Q3 | $4.14M | Sell |
17,774
-6
| -0% | -$1.4K | 2.02% | 25 |
|
|
2019
Q2 | $4.16M | Sell |
17,780
-63
| -0.4% | -$14.7K | 2.02% | 23 |
|
|
2019
Q1 | $4.22M | Buy |
+17,843
| New | +$4.22M | 2% | 23 |
|
|
2018
Q3 | $6.49M | Sell |
18,368
-6,803
| -27% | -$2.4M | 2.78% | 18 |
|
|
2018
Q2 | $7.31M | Hold |
25,171
| – | – | 2.79% | 17 |
|
|
2018
Q1 | $6.89M | Buy |
25,171
+489
| +2% | +$134K | 2.5% | 21 |
|
|
2017
Q4 | $7.86M | Buy |
24,682
+135
| +0.5% | +$43K | 2.32% | 18 |
|
|
2017
Q3 | $7.69M | Sell |
24,547
-998
| -4% | -$312K | 2.42% | 20 |
|
|
2017
Q2 | $6.93M | Sell |
25,545
-12
| -0% | -$3.26K | 2.17% | 21 |
|
|
2017
Q1 | $6.99M | Buy |
25,557
+2,278
| +10% | +$623K | 2.14% | 22 |
|
|
2016
Q4 | $6.6M | Sell |
23,279
-199
| -0.8% | -$56.4K | 2.08% | 20 |
|
|
2016
Q3 | $7.35M | Sell |
23,478
-225
| -0.9% | -$70.4K | 2.78% | 17 |
|
|
2016
Q2 | $5.73M | Sell |
23,703
-150
| -0.6% | -$36.3K | 2.24% | 19 |
|
|
2016
Q1 | $6.21M | Buy |
+23,853
| New | +$6.21M | 2.53% | 19 |
|